neurocare group AG Expands Mental Health Services in the U.S. with Mid-Ohio Behavioral Health Partnership
In a significant move for mental health services, neurocare group AG is broadening its international reach by partnering with Mid-Ohio Behavioral Health, a leading provider with five outpatient clinics in the Mid-Ohio region. This alliance underscores neurocare’s commitment to innovative therapies, particularly in the realm of Transcranial Magnetic Stimulation (TMS) therapy, a key component of their treatment offerings.
The announcement, made on July 15, 2025, highlights neurocare’s Apollo TMS Therapy, which has been proven to be an effective treatment for major depression. TMS therapy uses magnetic fields to stimulate nerve cells in the brain, providing a non-invasive alternative for patients who may not respond well to traditional medications.
Leadership Insights
Tom Mechtersheimer, the Founder and CEO of neurocare, expressed optimism about this new partnership. “We’re pleased to further expand the reach of our unique platform,” he shared. This platform uniquely combines neuromodulation technology with personalized treatment protocols, sleep integration, and comprehensive clinician training. The partnership will enhance the quality of care that Mid-Ohio Behavioral Health can offer its patients.
Dr. Ajay Sharma, Medical Director of Mid-Ohio Behavioral Health, echoed this sentiment. He noted that the collaboration with neurocare’s global network would enhance their existing high-quality care offerings. “Our team is passionate about delivering the highest quality care, and this opportunity will greatly enhance our abilities to provide cutting-edge treatments to our patients,” he commented.
Growing Network of Care
The inclusion of Mid-Ohio Behavioral Health significantly expands the reach of neurocare’s ‘neurocare Centers of America’ network, now encompassing over nine locations across four states, including major cities such as Long Island, Nashville, and Dallas. This growing network allows for the sharing of knowledge, techniques, and innovative treatments, making mental health care more accessible for those in need.
Pioneering Care in the Region
Founded in 2014, Mid-Ohio Behavioral Health has been at the forefront of TMS therapy in the Midwest. They’re already offering neurocare’s Apollo TMS therapy, allowing seamless integration of advanced treatment protocols. The partnership not only facilitates access to innovative technologies but also brings together resources such as an online educational academy for continuous professional development.
Addressing Mental Health Needs
The urgency for enhanced mental health services is underscored by the statistic that over 8 million adults in the U.S. experience major depression, often with unsatisfactory results from traditional medication. Neurocare group AG, which was established in Europe in 2015, aims to meet this pressing need for non-invasive, medication-free treatments. Their services provide valuable alternatives that target improved mental health outcomes through personalized approaches.
About Mid-Ohio Behavioral Health
Mid-Ohio Behavioral Health offers a holistic array of outpatient mental health services across five locations, prominently including Columbus and its surrounding areas. Services extend beyond TMS therapy to include diagnostic assessments, individual and group therapy, family counseling, and comprehensive case management, delivered by a multidisciplinary team of qualified professionals.
About neurocare group AG
neurocare group AG has established a best practice mental health platform designed to empower clinicians in delivering personalized therapy with sustainable outcomes. Their integrative approach combines psychotherapy, neuromodulation, and sleep hygiene with medication management, ensuring a holistic treatment experience. This platform incorporates in-house developed technologies, including leading TMS and EEG devices, cloud-based software, and focuses on enhancing clinicians’ skills through ongoing education.
Contact Information
For further inquiries, please contact:
Sally Remington
Global Marketing Manager
media@neurocaregroup.com
+49 152 2305 8385
This expansion and collaboration serve as a beacon of hope for patients seeking innovative mental health solutions within the Midwest, paving the way for enhanced accessibility and personalized care.
